Κυριακή 22 Μαρτίου 2020


Esophageal, gastric cancer and immunotherapy: small steps in the right direction?
Related ArticlesEsophageal, gastric cancer and immunotherapy: small steps in the right direction? Transl Gastroenterol Hepatol. 2020;5:9 Authors: Zayac A, Almhanna K Abstract The treatment of advanced, solid-tumor oncology has been reshaped over the last eight years with the development and FDA approval of several immune checkpoint inhibitors (ICIs) comprised of monoclonal antibodies targeting either PD-1, PD-L1, or CTLA-4 across numerous disease...
pubmed: future oncology
Fri Mar 20, 2020 13:53
Hepatobiliary cancers and immunotherapy: where are we now and where are we heading?
Related ArticlesHepatobiliary cancers and immunotherapy: where are we now and where are we heading? Transl Gastroenterol Hepatol. 2020;5:8 Authors: Zayac A, Almhanna K Abstract Primary liver cancers are a heterogenous collection of diseases with variable natural histories and treatments. This review article will focus on hepatocellular carcinoma (HCC), intrahepatic and extrahepatic cholangiocarcinoma, and gallbladder cancer, and the use of immune...
pubmed: future oncology
Fri Mar 20, 2020 13:53
Nab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: review and future directions.
Related ArticlesNab-paclitaxel and atezolizumab for the treatment of PD-L1-positive, metastatic triple-negative breast cancer: review and future directions. Expert Rev Precis Med Drug Dev. 2020;5(2):59-65 Authors: Kagihara JA, Andress M, Diamond JR Abstract Introduction: Breast cancer is the most common malignancy in women in the United States and triple-negative breast cancer (TNBC) accounts for 15-20%. The standard of care for metastatic TNBC has...
pubmed: future oncology
Fri Mar 20, 2020 13:53
Personalized selective internal radiation therapy in liver metastasis of thyroid cancer with impaired liver function: A case report.
Related ArticlesPersonalized selective internal radiation therapy in liver metastasis of thyroid cancer with impaired liver function: A case report. Radiol Case Rep. 2020 May;15(5):548-551 Authors: Herchuelz M, Marin G, Derijckere ID, Vouche M, Delatte P, Donckier V, Liberale G, Hendlisz A, Artigas C, Bourgeois P, Flamen P Abstract Follicular thyroid cancer (FTC) is a less common form of differentiated thyroid cancer. Liver metastasis of differentiated...
pubmed: future oncology
Fri Mar 20, 2020 13:53
Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database.
Related ArticlesOptimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database. Sci Rep. 2020 Mar 18;10(1):4926 Authors: Buszek SM, Al Feghali KA, Elhalawani H, Chevli N, Allen PK, Chung C Abstract Treatment for glioblastoma (GBM) includes surgical resection and adjuvant radiotherapy (RT) and chemotherapy. The optimal time interval between surgery and RT remains...
pubmed: future oncology
Fri Mar 20, 2020 12:55
Helical tomotherapy: Comparison of Hi-ART and Radixact clinical patient treatments at the Technical University of Munich.
Related ArticlesHelical tomotherapy: Comparison of Hi-ART and Radixact clinical patient treatments at the Technical University of Munich. Sci Rep. 2020 Mar 18;10(1):4928 Authors: Kraus KM, Kampfer S, Wilkens JJ, Schüttrumpf L, Combs SE Abstract The helical tomotherapy (HT) Hi-ART system was installed at our department in April 2007. In July 2018 the first Radixact system in Germany has been launched for clinical use. We present differences, advantages...
pubmed: future oncology
Fri Mar 20, 2020 12:55
High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer.
Related ArticlesHigh hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer. Breast Cancer Res. 2020 Mar 18;22(1):30 Authors: Qiu SQ, van Rooijen J, Nienhuis HH, van der Vegt B, Timmer-Bosscha H, van Leeuwen-Stok E, Walenkamp AME, van Deurzen CHM, de Bock GH, de Vries EGE, Schröder CP Abstract BACKGROUND: Breast cancer is rare in men, but management is focused on tumor characteristics commonly...
pubmed: future oncology
Fri Mar 20, 2020 12:55
Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia.
Related ArticlesLandscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia. J Clin Med. 2020 Mar 16;9(3): Authors: Panuzzo C, Signorino E, Calabrese C, Ali MS, Petiti J, Bracco E, Cilloni D Abstract Acute myeloid leukemia is mainly characterized by a complex and dynamic genomic instability. Next-generation sequencing has significantly improved the ability of diagnostic research to molecularly characterize and stratify patients. This detailed...
pubmed: future oncology
Fri Mar 20, 2020 12:55
BIGART 2019 - adapting to the future.
Related ArticlesBIGART 2019 - adapting to the future. Acta Oncol. 2019 Oct;58(10):1323-1327 Authors: Overgaard J, Muren LP, Høyer M, Grau C PMID: 31642743 [PubMed - indexed for MEDLINE]
pubmed: future oncology
Fri Mar 20, 2020 12:55
Prognostic Models for Predicting Overall Survival in Patients with Primary Gastric Cancer: A Systematic Review.
Related ArticlesPrognostic Models for Predicting Overall Survival in Patients with Primary Gastric Cancer: A Systematic Review. Biomed Res Int. 2019;2019:5634598 Authors: Feng Q, May MT, Ingle S, Lu M, Yang Z, Tang J Abstract Background: This study was designed to review the methodology and reporting of gastric cancer prognostic models and identify potential problems in model development. Methods: This systematic review was conducted following...
pubmed: future oncology
Fri Mar 20, 2020 12:55
Evolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III project.
Related ArticlesEvolution of older patients diagnosed with early breast cancer in Spain between 1998 and 2001 included in El Alamo III project. Clin Transl Oncol. 2019 Dec;21(12):1746-1753 Authors: Torregrosa MD, Escudero MJ, Paredero I, Carrasco E, Bermejo B, Gavila J, García-Saenz J, Santaballa A, Martínez P, Llombart A, Andrés R, Batista N, Fernández A, Antón A, Seguí M, Gonzalez S, Ruiz A, GEICAM, the Spanish Breast Cancer Group Abstract INTRODUCTION:...
pubmed: future oncology
Fri Mar 20, 2020 12:55
The current state of molecular testing in the treatment of patients with solid tumors, 2019.
Related ArticlesThe current state of molecular testing in the treatment of patients with solid tumors, 2019. CA Cancer J Clin. 2019 07;69(4):305-343 Authors: El-Deiry WS, Goldberg RM, Lenz HJ, Shields AF, Gibney GT, Tan AR, Brown J, Eisenberg B, Heath EI, Phuphanich S, Kim E, Brenner AJ, Marshall JL Abstract The world of molecular profiling has undergone revolutionary changes over the last few years as knowledge, technology, and even standard clinical...
pubmed: future oncology
Fri Mar 20, 2020 12:55
Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy.
Related ArticlesPrevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy. Clin Transl Oncol. 2019 Dec;21(12):1707-1711 Authors: Ferrero VT, Oset MM, Masferrer JP, Pardo EH, Sorolla EJ, Largo SC, PrevaDIOR Study Group Abstract PURPOSE: Radiotherapy-induced dysfunction of the gastrointestinal tract is common in cancer patients and has a significant impact on their quality of life. In this...
pubmed: future oncology
Fri Mar 20, 2020 12:55
Machine Learning in Nuclear Medicine: Part 1-Introduction.
Related ArticlesMachine Learning in Nuclear Medicine: Part 1-Introduction. J Nucl Med. 2019 04;60(4):451-458 Authors: Uribe CF, Mathotaarachchi S, Gaudet V, Smith KC, Rosa-Neto P, Bénard F, Black SE, Zukotynski K Abstract This article, the first in a 2-part series, provides an introduction to machine learning (ML) in a nuclear medicine context. This part addresses the history of ML and describes common algorithms, with illustrations of when they can...
pubmed: future oncology
Fri Mar 20, 2020 12:55
Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry.
Related ArticlesLabyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry. Antiviral Res. 2020 Mar 17;:104774 Authors: Blockus S, Sake SM, Wetzke M, Grethe C, Graalmann T, Pils M, Le Goffic R, Galloux M, Prochnow H, Rox K, Hüttel S, Rupcic Z, Wiegmann B, Dijkman R, Rameix-Welti MA, Eléouët JF, Duprex WP, Thiel V, Hansen G, Brönstrup M, Haid S, Pietschmann T Abstract Acute lower respiratory tract infections (ALRI) caused...
Upper respiratory tract infection
Sun Mar 22, 2020 14:14
Practical recommendations for the perioperative management of the patient with suspection or serious infection by coronavirus SARS-CoV.
Related ArticlesPractical recommendations for the perioperative management of the patient with suspection or serious infection by coronavirus SARS-CoV. Rev Esp Anestesiol Reanim. 2020 Mar 17;: Authors: Montero Feijoo A, Maseda E, Adalia Bartolomé R, Aguilar G, González de Castro R, Gómez-Herreras JI, García Palenciano C, Pereira J, Ramasco Rueda F, Samso E, Suárez de la Rica A, Tamayo Medel G, Varela Durán M, en nombre del Grupo de Trabajo de Infección Perioperatoria...
Upper respiratory tract infection
Sun Mar 22, 2020 14:14
16HBE Cell Lipid Mediator Responses to Mono and Co-Infections with Respiratory Pathogens.
Related Articles16HBE Cell Lipid Mediator Responses to Mono and Co-Infections with Respiratory Pathogens. Metabolites. 2020 Mar 18;10(3): Authors: Schultz D, Surabhi S, Stelling N, Rothe M, Group KS, Methling K, Hammerschmidt S, Siemens N, Lalk M Abstract Respiratory tract infections are a global health problem. The main causative agents of these infections are influenza A virus (IAV), Staphylococcus aureus (S. aureus), and Streptococcus pneumoniae...
Upper respiratory tract infection
Sun Mar 22, 2020 12:16

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου